EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma

Josephine Q N Nguyen, Wojtek Drabarek, Aïsha M C H J Leeflang, Tom Brands, Thierry P P van den Bosch, Robert M Verdijk, Harmen J G van de Werken, Job van Riet, Dion Paridaens, Annelies de Klein, Erwin Brosens, Emine Kiliç und 1 weitere

Investigative Ophthalmology & Visual Science · 2024

DOI: 10.1167/iovs.65.12.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2024. Verfasst von Josephine Q N Nguyen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: RNA Splicing Factors, Uveal Neoplasms, Melanoma, Spliceosomes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splicing FactorsUveal NeoplasmsMelanomaSpliceosomesPhosphoproteinsApoptosisMutationHumansCell SurvivalCell Line, TumorUbiquitin ThiolesteraseTumor Cells, CulturedRibonucleoprotein, U2 Small NuclearRNA SplicingGene Expression Regulation, NeoplasticEpoxy CompoundsMacrolidesTumor Suppressor ProteinsUveal Melanoma

Substanzen

RNA Splicing FactorsSF3B1 protein, humanPhosphoproteinsE 7107Ubiquitin ThiolesteraseRibonucleoprotein, U2 Small NuclearBAP1 protein, humanEpoxy CompoundsMacrolidesTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.
  • Department of Clinical Genetics, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.
  • The Rotterdam Eye Hospital, BH Rotterdam, The Netherlands.
  • Department of Pathology, Section Ophthalmic Pathology, Erasmus MC Cancer Institute, Erasmus MC Medical Center Rotterdam, CA Rotterdam, The Netherlands.
  • Department of Pathology, Leiden University Medical Center, ZA Leiden, The Netherlands.
  • Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center Rotterdam, CA Rotterdam, The Netherlands.

Zitieren

APA

Nguyen, J. Q. N., Drabarek, W., Leeflang, A. M. C. H. J., Brands, T., van den Bosch, T. P. P., Verdijk, R. M., van de Werken, H. J. G., van Riet, J., Paridaens, D., de Klein, A., Brosens, E., Kiliç, E., & Rotterdam Ocular Melanoma Study Group (2024). The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.12.11

Vancouver

Nguyen JQN, Drabarek W, Leeflang AMCHJ, Brands T, van den Bosch TPP, Verdijk RM, et al. The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.12.11

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Josephine Q N and Drabarek, Wojtek and Leeflang, Aïsha M C H J and Brands, Tom and van den Bosch, Thierry P P and Verdijk, Robert M and van de Werken, Harmen J G and van Riet, Job and Paridaens, Dion and de Klein, Annelies and Brosens, Erwin and Kiliç, Emine and Rotterdam Ocular Melanoma Study Group, Rotterdam Ocular Melanoma Study Group},
  title = {The Impact of Spliceosome Inhibition in SF3B1 -Mutated Uveal Melanoma},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  doi = {10.1167/iovs.65.12.11}
}
Kostenlos starten →